Domain intelligence: WHOIS (registrar, creation and expiry dates), DNS records and SSL certificate details.

Check any wallet balance across 5 EVM chains. Returns native or ERC-20 balance with threshold check, block height, and on-chain receipt. Supports Base, Ethereum, Arbitrum, Optimism, and Polygon.

About the .aero top-level domain: registry operator, type (generic, country-code, sponsored), IANA/RDAP details, WHOIS server, creation date, DNSSEC signing status and the registry's nameservers. Registration research and TLD-policy checks for .aero. $0.01 per call.

Fonarow 2005 ADHERE CART bedside tree from admission BUN, systolic BP, and serum creatinine. high: BUN>=43, SBP<115, Cr>=2.75; intermediate_1: BUN>=43, SBP<115, Cr<2.75; intermediate_2: BUN>=43, SBP>=115; intermediate_3: BUN<43, SBP<115; low: BUN<43, SBP>=115. Creatinine consulted only when BUN>=43 and SBP<115. CART tree only, not the logistic model or GWTG-HF. Not a heart-failure diagnosis or treatment/ICU order.

AAP 2017 Flynn Table 3 pediatric BP category (normal, elevated, stage_1, stage_2) from age 1-17 and cuff mm Hg. Age ≥13 uses adult-aligned 120/80, 130/80, and 140/90 cutoffs. Age 1-12 needs caller 90th/95th mm Hg (magent does not interpolate height/sex tables). Category is the more severe limb. magent does not measure BP. Not a device, not a hypertension diagnosis, not the 2004 Fourth Report, and not ACC/AHA 2017 for age <13.

Pocock 2013 MAGGIC integer score from 13 heart-failure predictors (age, EF, NYHA, creatinine, diabetes, not prescribed beta-blocker, SBP, BMI, HF duration >18 months, current smoker, COPD, male sex, not prescribed ACEI/ARB), including the published age×EF and SBP×EF extras. Returns integer score and Table 4 1-year and 3-year death probabilities for scores 0-50. Not a diagnosis, not a treatment order, not a reason to withhold therapy. magent does not examine the patient.

Lyon 2020 HFA-ICOS baseline cardiovascular risk before anthracycline chemotherapy. Returns risk_level low, medium, high, or very_high from published Very high, High, Medium 2, and Medium 1 factors, plus medium_points and the paper's expert-opinion cardiotoxicity_guide. Age and LVEF use the highest matching printed band only. Caller assigns labs and BMI >30. magent does not examine the patient or read imaging. Not a medical device or treatment order.

Fick 1870 cardiac output: CO (L/min) = VO2 (ml/min) / (CaO2 - CvO2) with contents in ml/L (ml/dL x10). Caller supplies the three measured terms. Does not estimate VO2 from BSA or apply Hufner Hb factors. Rejects CaO2 <= CvO2. Not a catheter order, shock diagnosis, or medical device. magent does not sample blood.

Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL. Class is very_high, high, medium, or low from published very-high and high factors plus Medium 1/2 points (0–1 low, 2–4 medium, ≥5 high). Caller assigns the 10-year CVD >20% threshold; magent does not compute that score. Not a medical device or treatment order.

Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents). Very high, high, medium, or low from published factors plus Medium 1/2 points; expert-opinion cardiotoxicity guide <2% / 2-9% / 10-19% / >=20%. Concurrent anthracycline is High; sequential anthracycline before HER2 is Medium 1. Deterministic published classification with citation; not a treatment order. magent does not measure LVEF or biomarkers.

Lyon 2020 HFA-ICOS baseline CV risk before proteasome inhibitors and immunomodulatory drugs for multiple myeloma. Returns risk_level low, medium, high, or very_high plus medium_points and the paper's expert-opinion cardiotoxicity_guide. Age >=75 is High; 65-74 is Medium 1. Caller assigns labs, BMI >30, and high-dose dexamethasone. magent does not examine the patient or read imaging. Not a medical device or treatment order.

Rahman 2014 RAPID score for pleural infection: urea (<5=0, 5-8=1, >8=2 mmol/L), age (<50=0, 50-70=1, >70=2), non-purulent fluid 1, hospital-acquired 1, albumin <27 g/L 1; total 0-7 with low/medium/high bands. Deterministic published arithmetic with citation; not a drain or surgery decision and not Light's criteria.

Lyon 2020 HFA-ICOS baseline CV risk before VEGF inhibitors or VEGF TKIs. Very high if heart failure/cardiomyopathy or arterial vascular disease. High if venous thrombosis, LVEF <50%, QTc >=480 ms, age >=75, hypertension, prior anthracycline, or >=5 medium points. Medium if 2-4 medium points. Guide <2% / 2-9% / 10-19% / >=20%. Not a device or treatment order.

Gajic 2011 lung injury prediction score (Table 3): caller-assigned predisposing conditions, at most one high-risk surgery type plus emergency add-on, stacking trauma items, and risk modifiers including diabetes -1 only with sepsis. Score is a number; published observed range 0-15.5. Band low if <4, high if >=4 (ROC cutoff). Not an ARDS diagnosis. magent does not examine the patient or read imaging.

Ley 2012 GAP index (points) from sex (male 1), age (≤60 → 0, 61–65 → 1, >65 → 2), FVC % predicted (>75 → 0, 50–75 → 1, <50 → 2), and DLCO % predicted (>55 → 0, 36–55 → 1, ≤35 → 2; cannot perform → 3). Returns a 0–8 total and stage 1–3 (0–3 / 4–5 / 6–8). Deterministic published points with citation. Not a transplant listing and not a continuous GAP calculator.

Rapid shallow breathing index (RSBI) as respiratory rate in breaths/min divided by tidal volume in liters (Yang and Tobin 1991). Provide tidal_volume_ml (50–2000) or tidal_volume_l (0.05–2.0), not both. Returns f/VT rounded to one decimal and whether that ratio is greater than 105 breaths/min/L. Not a wean order; magent does not perform a spontaneous breathing trial (SBT).

Dakik 2019 AUB-HAS2 for 30-day death/MI/stroke after noncardiac surgery: six 1-point elements (history of heart disease, angina or dyspnea, age ≥75, hemoglobin <12 g/dL, vascular surgery, emergency surgery). Low 0-1, intermediate 2-3, high >3 (max 6). Derivation rates 0%, 0.5%, 2.0%, 5.6%, 15.7% by score 0/1/2/3/>3. Not a medical device, not RCRI, not ACS treatment, and not operative clearance.

Gupta 2024 Figure 2 simple CP-AKI score after first IV cisplatin: age, hypertension, diabetes, current or former smoking, hemoglobin g/L, WBC, albumin g/L, magnesium mmol/L, and cisplatin dose mg. Max 22.5. Low / moderate / high / very_high. Not a diagnosis or chemo order. magent does not assay labs or dose cisplatin.

Daugirdas 1993 second-generation single-pool variable-volume Kt/V. Kt/V = -ln(R - 0.008 * t) + (4 - 3.5 * R) * UF / W, with R = post_bun_mg_dl / pre_bun_mg_dl. Numeric Kt/V to 2 decimals. Not a dialysis prescription, not equilibrated eKt/V, not stdKt/V, and not a urea-reduction-ratio tool. magent does not assign KDOQI or other adequacy targets.

OPTN Policy 9 Table 9-1 PELD-Cr from age, albumin, bilirubin, INR, creatinine or dialysis/CVVHD, and caller-assigned minimum CDC height or weight Z-score. PELD = (sum of Table 9-1 terms + 1.5287) × 10 + 2.82; nearest integer; minimum 6. Albumin, bilirubin, and INR floor at 1.0; creatinine 1.3 mg/dL if >1.3 or dialysis/CVVHD. Not a transplant listing order. magent does not compute CDC LMS Z from height or weight.